Ut. Seyfert et F. Jung, Criteria and principles of in vitro hemocompatibility testing according tothe ISO 10993(4), INFUS THER, 27(6), 2000, pp. 317-322
Citations number
21
Categorie Soggetti
Hematology
Journal title
INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
The development of synthetic materials and textured polymers and their incr
easing use in medicine make research of biomaterials' hemocompatibility ver
y relevant. Problems arise from the polymorphism and diversity of the diffe
rent materials, the static and dynamic test models, and the patients' indiv
idual biological factors. First, methods, models, tests as well as preanaly
tical factors have to be standardized according to the current knowledge in
medicine laid down in the ISO 10993(4) and in the guidelines given by the
relevant German medical societies and the Federal Chamber of Physicians (Bu
ndesarztekammer). The routine controls used in clinical chemistry and hemat
ology have to be performed. Information about normal ranges (mean value, st
andard deviation, 95% confidence interval) should be provided. Tests have t
o be performed within a minimal delay of usually 2 h since some properties
of blood change rapidly following collection. Various conditions (depending
on the wall shear rate) were simulated within the centrifugation system an
d the Chandler system. Quality and aspects of hemocompatibility such as pla
telet activation, oxidative burst, hemolysis, fibrinolysis, fibrin formatio
n, generation of thrombin, contact activation, and complement activation we
re analyzed, and the results were entered into a nondimensional score syste
m, where 0 points stand for the best and 65 points for the worst evaluation
. In a low low shear stress system, we found good correlations between the
total score and i) contact activation, ii) thrombin generation and iii) leu
kocyte activation; in a high shear stress system good correlations were dem
onstrated between the total score and i) thrombin generation, ii) hemolysis
and iii) platelet activation. Furthermore, the effect of additives can be
measured. The concepts presented underline the relevance/importance of an e
fficient diagnostic approach to hemocompatibility that takes account of cli
nical and socioeconomic concerns.